EZH2 and melanoma: Inhibition of EZH2 enabled IFN-γ-induced MHCII expression by increasing chromatin accessibility at the CIITA. In addition, an inverse correlation between PRC2 complex-related gene expression and the response to anti-PD-1 treatment was found in melanoma patients [119].